CD4 and systemic lupus erythematosus: To evaluate the impact of glucose metabolic reprogramming in patients with SLE, we initially assessed the oxidative phosphorylation and glycolysis profiles of activated SLE‐CD4+ T cell through real‐time metabolic analysis utilizing Agilent seahorse XF24 analyzer.